Epstein-Barr virus-negative classical Hodgkin's lymphoma in a patient with T-cell prolymphocytic leukemia treated with fludarabine.
Takahiro
T
Tsuji
Hiroshi
H
Yamasaki
Nobuyuki
N
Arima
Daisuke
D
Niino
Koichi
K
Ohshima
Hiroyuki
H
Tsuda
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D004854:Herpesvirus 4, Human; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D015461:Leukemia, Prolymphocytic, T-Cell / Q000139:chemically induced / Q000473:pathology*; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000139:chemically induced / Q000473:pathology*; D014740:Vidarabine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D014740:Vidarabine; C024352:fludarabine